Jonathan Violin - Chief Executive Officer, Viridian Therapeutics, Inc\de

As of June 2, 2022


What is Jonathan Violin's Net Worth?

The current estimated net worth of Viridian Therapeutics, Inc\de's Chief Executive Officer, Jonathan Violin, is estimated to be about $3.22M . Jonathan Violin owns about 480,905 units of Viridian Therapeutics, Inc\de common stock. In the last year at Viridian Therapeutics, Inc\de, Jonathan Violin has sold an estimated value of $2.43M worth.

What is Jonathan Violin's Past Insider Trading?

Jonathan Violin's largest sale order was 30,000 units , worth over $572.82K on February 3, 2022. In total, Jonathan Violin has made about 7 transactions over a year of their time at Viridian Therapeutics, Inc\de. Jonathan Violin usually trades in April, February, March, January, May, December and June, with the busiest year in 2022. The most recent transaction was a sale order of 30,000 units , worth over $366K on June 2, 2022.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is Jonathan Violin's' Mailing Address?

  • Mailing address is 955 Chesterbrook Boulevard Suite 200 Chesterbrook PA 19087 PA

Viridian Therapeutics, Inc\de Executive Compensation

Name
Year
Salary
Bonus
Option Awards
Other Compensation
Total
William S. Marshall, Ph.D. 2020 $424,832 - $585,128 $1,176,859 $2,186,819
William S. Marshall, Ph.D. 2019 $521,000 - $551,302 $3,640 $1,075,942
Lee Rauch 2020 $256,436 $270,500 $1,139,677 $3,798 $1,670,411
Jason A. Leverone 2020 $365,650 - $112,715 $4,655 $483,020
Jason A. Leverone 2019 $355,000 - $178,223 $4,584 $537,807
Diana Escolar, M.D. 2020 $417,473 $277,780 $164,492 $5,873 $865,618
Diana Escolar, M.D. 2019 $372,600 $111,780 $59,408 $6,217 $550,005
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1590750/000159075021000054/vrdn-20210430defx14a.htm

What are Viridian Therapeutics, Inc\de's Past Insider Trades?

Viridian Therapeutics, Inc\de's most recent insider trade came on June 2, 2022 by Jonathan Violin who sold 30,000 units worth $366K . In the last year, insiders at Viridian Therapeutics, Inc\de have sold an estimated value of $2.43M and bought an estimated value of $12.2M worth of shares. Insider trading is most common in February, with the busiest year in 2021. The most active traders at the company are Jonathan Violin, Chief Executive Officer,  Arlene Morris, Director,  and Kristian Humer, CFO and CBO .

Viridian Therapeutics, Inc.\DE Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1